Introduction
============

Small nucleolar RNAs (snoRNAs) are nuclear noncoding RNAs that primarily guide 2′-*O*-ribose methylation and posttranscriptional isomerization of uridine to pseudouridine in various RNA molecules, including very abundant and heavily modified ribosomal RNAs and spliceosomal U snRNAs. Therefore, snoRNAs are often referred to as modification guide RNAs. All pseudouridylation guide RNAs are characterized by short motifs called H (ANANNA) and ACA (ACA or AUA trinucleotide) boxes, and a distinctive "hairpin--hinge--hairpin--tail" secondary structure with the H and ACA boxes located in the hinge and tail regions, respectively. The hairpins form internal loops, or pseudouridylation pockets. The single-stranded sides of these loops serve as antisense elements that base-pair with substrate RNAs flanking the target uridine. 2′-*O*-methylation guide RNAs are distinguished by C/C′ (RUGAUGA) and D/D′ (CUGA) boxes and sequences complementary to substrate RNAs, or antisense elements, located upstream of D-box motifs (reviewed by [@msz209-B68]). Thus, sequence conservation of this class of RNAs is basically limited to antisense elements and "boxes."

Evolutionary studies of snoRNA conservation and diversity are based mostly on snoRNA gene annotations from publicly available genome assemblies ([@msz209-B17]; [@msz209-B29]). A number of genomic snoRNA scanning tools ([@msz209-B36]; [@msz209-B49]; [@msz209-B67]; [@msz209-B14]; [@msz209-B16]; [@msz209-B1]) and target prediction tools ([@msz209-B2]; [@msz209-B55]; [@msz209-B28][@msz209-B29]) are available and they are crucial for snoRNA annotation. However, their usage is restricted by our knowledge of the functional interaction between a guide RNA and its corresponding substrate RNA, such as the minimal length of antisense elements, the maximal number of mismatches and/or noncanonical pairs, and the stringency and flexibility of RNA secondary structure. Moreover, the motif-based search for snoRNA sequences can pick up pseudogenes or snoRNA-like remnants that never express, while leaving genuine snoRNAs with noncanonical structure undetected. Experimental RNA coimmunoprecipitation has been productive in the discovery of novel snoRNAs ([@msz209-B32]; [@msz209-B60]; [@msz209-B22]; [@msz209-B10]; [@msz209-B30]; [@msz209-B37]). However, deep sequencing of such RNA samples shows that they may be highly contaminated ([@msz209-B22]). Thus, despite many efforts, annotation of modification guide RNAs in higher eukaryotes is still far from complete. Even in the well-studied mouse and human a number of conserved snoRNAs remain "orphan," whereas certain well-characterized modifications in rRNAs and snRNAs have no assigned snoRNAs (<https://www-snorna.biotoul.fr/index.php>, <http://www.bioinf.uni-leipzig.de/publications/supplements/15-065>; last accessed August 16, 2019) (Lestrade and Weber [@msz209-B34]; [@msz209-B24]). Furthermore, a better understanding of evolution-driven snoRNA conservation and divergence requires nearly complete sets of snoRNAs, especially from nonmammalian species.

Studies from our laboratory ([@msz209-B15]; [@msz209-B56]) demonstrated the advantages of the *Xenopus* oocyte in searching for missing snoRNAs. Amphibian oocytes are enormously large cells with a giant nucleus (also called germinal vesicle, or GV). GVs can be isolated manually from oocytes, providing 2 ng of pure nuclear RNA from a single cell. The box C/D and box H/ACA modification guide RNAs normally reside in the nucleus where rRNAs and snRNAs are modified ([@msz209-B40]; [@msz209-B69]; [@msz209-B21]). Most snoRNAs are encoded within introns, and their proper processing relies on splicing, which is a nuclear event as well. Thus, after rRNA depletion, GV RNA is a good source of snoRNAs without any additional enrichment or size selection. We chose *Xenopus tropicalis* GV RNA for our snoRNA search because 1) the *X. tropicalis* genome is relatively small and has been sequenced, 2) pure GV RNA samples have already been obtained and the high-throughput sequencing data are available for further analysis, and 3) many highly conserved snoRNAs have already been annotated in *Xenopus*. In this study we scanned through the nuclear transcriptomes of *X. tropicalis* and successfully annotated 90% of human orthologous snoRNAs. In addition, we identified 30 new *Xenopus* snoRNAs. Having "complete" snoRNA sets from *Amphibia* and *Mammalia*, supplemented with subsets of orthologous snoRNAs annotated and newly identified in birds, reptiles, and fish, we performed interspecies comparative analysis of snoRNA modification target predictions and modification patterns of rRNAs and snRNAs. Our findings suggest that snoRNA--substrate assignments are not as conserved as generally believed and that a point mutation in a highly conserved snoRNA can result in loss or gain of function in targeting a substrate RNA for modification. Furthermore, we hypothesize that 5′- and 3′-terminal domains in snoRNAs evolve and migrate within the genome as independent units.

Results
=======

Completion of *Xenopus* snoRNA Annotation
-----------------------------------------

Although the *Xenopus tropicalis* genome is now relatively well assembled (<http://www.xenbase.org>; last accessed August 16, 2019) ([@msz209-B27]), snoRNA annotation is still incomplete---only about 100 snoRNAs have been annotated so far. To find new box C/D and box H/ACA guide RNAs in the *Xenopus* genome, we analyzed abundant transcripts in a nuclear RNA fraction isolated from *X. tropicalis* oocytes, or in GV RNA (SRA data: SRP066274, SRX4895193). After rRNA depletion this fraction consists predominantly of stable intronic RNAs, including snoRNAs, and a few types of abundant nuclear RNAs, such as U snRNAs, 7SK, and RNaseP. The latter sequences can be easily identified and excluded from the analysis. Details of this analysis are described in the Materials and Methods section. This approach allowed us to identify 422 snoRNAs in the *X. tropicalis* genome ([supplementary table 1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). The list includes additional copies of previously annotated snoRNAs and newly identified *Xenopus* snoRNAs. Among these are *Xenopus* orthologs of known human snoRNAs and snoRNAs that do not have annotated homologs in any other species; the latter are highlighted in [supplementary table 1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online. For snoRNA annotation in the xentro9 genome assembly, we provide these data in a BED file format ("BED" tab in [supplementary table 1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online).

Overall, we have identified most *Xenopus* orthologs of annotated human snoRNAs. We expected some guide RNAs to be absent from the *Xenopus* genome because the corresponding modifications do not occur in *Xenopus* 18S and 28S rRNAs ([@msz209-B38][@msz209-B39]; our data). However, a few guide RNAs for highly conserved modifications were not found, presumably because the reference genome is not complete. SNORD69 is an example of such an snoRNA ([fig. 1](#msz209-F1){ref-type="fig"}). In humans, this box C/D snoRNA is annotated as a guide RNA for 2′-*O*-methylation of 28S rRNA at position G4464 and is encoded in an intron of the *gnl3* gene, which also hosts SNORD19 ([fig. 1*A*](#msz209-F1){ref-type="fig"}). In the *Xenopus* genome assembly, *gnl3* contains several gaps, of which one is in the region where SNORD69 is expected ([fig. 1*A* and *B*](#msz209-F1){ref-type="fig"}). We amplified and sequenced a genomic fragment from this region of the *Xenopus gnl3* gene. When this fragment was incorporated in the *gnl3* gene model and RNA-sequencing reads were mapped to the improved gene model, SNORD69 became evident ([fig. 1*B*](#msz209-F1){ref-type="fig"}, blue). The expression of SNORD69 in *Xenopus* somatic cells and oocytes was verified by northern blot analysis ([fig. 1*C*](#msz209-F1){ref-type="fig"}). Thus, missing snoRNAs will be found once a better genome assembly is available for *Xenopus*.

![SNORD19/SNORD69 snoRNA family. (*A*) Schematic gene models of the *GNL3* gene harboring SNORD19 (red) and SNORD69 (blue) snoRNAs in different vertebrate species. The current assembly of the *Xenopus tropicalis* genome contains gaps indicated with Ns (top of the two *X. tropicalis* schemes). Using PCR amplification and sequencing, we filled the gap in *X. tropicalis gnl3* and annotated SNORD69 in this region (bottom of the two *X. tropicalis* schemes). (*B*) IGV browser view of deep-sequencing reads generated for RNA from cytoplasm and nuclei (germinal vesicles, or GV) of *X. tropicalis* oocytes and aligned to the *X. tropicalis* 9.1 genome (top two panels) or to the improved gene model (two bottom panels). Expression of SNORD69 (blue) along with SNORD19 (red) became evident when the de novo gene annotation was used. (*C*) Northern blot analysis of newly identified SNORD69 in *X. tropicalis*. RNA was isolated from 20 oocyte nuclei (GVs) and liver. (*D*) Clustal analysis of SNORD19/SNORD69 snoRNA family sequences from different taxonomic groups. All SNORD69 (blue) sequences cluster together regardless of their modification activity on 18S rRNA. Stars indicate SNORD69 sequences that are functional on both 28S and 18S rRNAs. (*E*) Postulated base-pairing of SNORD19 and SNORD69 snoRNAs from different species with 18S and 28S rRNAs. Experimentally verified guide activity is indicated for each snoRNA with a plus or minus sign (functional or nonfunctional at the listed position). For more details on the guide-RNA modification activity assay, see [supplementary figure 2](#sup1){ref-type="supplementary-material"}*A* and *D*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online. The positions of one-nucleotide variations critical for SNORD69 modification activity on 18S rRNA are marked with a star.](msz209f1){#msz209-F1}

Target Predictions for Known and Newly Identified snoRNAs in *Xenopus* and Human
--------------------------------------------------------------------------------

We analyzed all newly identified and previously annotated *Xenopus* and human snoRNAs for potential rRNA and snRNA targets. The results of this analysis are summarized in [supplementary table 1](#sup1){ref-type="supplementary-material"} and [supplementary figure 1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online. A similar analysis was performed earlier by other investigators ([@msz209-B29]; [@msz209-B24]). Many, but not all of our assignments coincide with previous predictions. All unexpected snoRNAs and predicted targets have been validated. To verify predicted modification guide RNA activities, we used an in vivo yeast cell system. *Saccharomyces cerevisiae* provides a favorable system because yeast cells support guide RNA-mediated posttranscriptional modification. At the same time, the number of modified positions is fewer than in higher eukaryotes and only five yeast snoRNAs are essential (<https://people.biochem.umass.edu/sfournier/fournierlab/snornadb/mastertable.php>; last accessed August 16, 2019, <https://www.yeastgenome.org>; last accessed August 16, 2019). In yeast, one can easily express exogenous guide RNAs from a plasmid, delete endogenous guide RNAs, and test predicted substrate RNAs for modifications. This system was previously used to test modification guide activity of *Drosophila* and vertebrate snoRNAs ([@msz209-B66]; [@msz209-B46]; [@msz209-B10][@msz209-B11][@msz209-B12]).

A subset of the verified predictions is listed in [table 1](#msz209-T1){ref-type="table"} and shown in [supplementary figures 2](#sup1){ref-type="supplementary-material"} and [3](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online. Specifically, we identified the orphan snoRNAs SNORA11 and SNORD89 as guide RNAs for positioning Ψ58 and Gm12 in U2 snRNA, well-known highly conserved modifications that had no assigned guide RNAs ([fig. 2](#msz209-F2){ref-type="fig"}). The predicted modification guide RNA activities were confirmed using a yeast cell system ([supplementary fig. 2](#sup1){ref-type="supplementary-material"}*B* and [supplementary table 2](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Because these snoRNAs modify U2 snRNA and contain canonical Cajal body localization signals, they should be reannotated as scaRNAs. We also predicted that SNORA57 could mediate pseudouridylation of 18S rRNA at position 1045 ([fig. 2](#msz209-F2){ref-type="fig"}) in addition to the previously assigned positions 1004 and 1046 ([@msz209-B24]); pseudouridines at positions 1045 and 1046 have been recently detected in human 18S rRNA ([@msz209-B5]; [@msz209-B58]), but 1045 has no guide RNA assigned so far. When experimentally tested in yeast cells, SNORA57 was able to modify all three predicted positions ([supplementary fig. 2](#sup1){ref-type="supplementary-material"}*C*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). In the *Xenopus* snoRNA set, we also identified an elusive guide RNA for positioning another recently identified pseudouridine in human 18S rRNA at position 1177. One of the two copies of *Xenopus* SNORA26 contains a pseudouridylation pocket specific for this position ([fig. 2](#msz209-F2){ref-type="fig"}). Notably, none of the SNORA26 copies from other species has an antisense element specific to 18S-Ψ1177. Similarly, in *Xenopus* SNORA4 and SNORA55, we identified antisense elements for positioning a highly conserved pseudouridine in 28S rRNA that is equivalent to human 28S-Ψ4323 ([fig. 2](#msz209-F2){ref-type="fig"} and [supplementary fig. 1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online), yet orthologous snoRNAs in other species are missing this antisense element. In birds, mammals and reptiles SNORA55 targets position 36 in 18S rRNA instead.

![Novel snoRNA assignments to previously known and recently identified orphan modifications in U2 snRNA, 18S and 28S rRNAs. For experimental verification of the predicted guide activities, see supplementary figures 2 and 4, [Supplementary Material](#sup1){ref-type="supplementary-material"} online.](msz209f2){#msz209-F2}

###### 

List of Experimentally Verified Novel Target Predictions for Evolutionarily Conserved Modification Guide RNAs.

  Guide RNA                                    Target Predictions Made[^a^](#tblfn1){ref-type="table-fn"}   Verification                                                                                                                                                                              
  -------------------------------------------- ------------------------------------------------------------ ---------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------
  SCARNA4                                      U2-41                                                        U2-41                                    U2-41                                                                                                                                            See [@msz209-B12] for details
  U2-39                                        ---                                                          ---                                                                                                                                                                                       
  SCARNA15                                     ---                                                          ---                                      U2-41 (all except placental)                                                                                                                     See [@msz209-B12] for details
  U2-37                                        U2-37/39                                                     U2-37/39                                                                                                                                                                                  
  SNORD19                                      18S-G683                                                     18S-G683/28S-G4464                       18S-G683/28S-G4464 (all species)                                                                                                                 Tested in yeast cell system
  SNORD69                                      28S-G4464                                                    28S-G4464                                28S-G4464/18S-G683 (fish)                                                                                                                        Tested in yeast cell system
  SNORD89                                      orphan                                                       U2-G12                                   U2-G12                                                                                                                                           Tested in yeast cell system
  SNORA11                                      18S-1350                                                     U2-58                                    U2-58                                                                                                                                            Tested in yeast cell system
  SNORA14                                      18S-681                                                      ---                                      18S-892 (amphibians, fish)                                                                                                                       Tested in yeast cell system, and in HeLa cells;
  18S-966                                      18S-966                                                      18S-966                                  SNORA55 modifies 18S-681                                                                                                                         
  SNORA22                                      28S-4966/4467                                                ---                                      ---                                                                                                                                              Tested in yeast, HeLa and XTC cells.
  28S-4975/18S-918                             18S-918/28S-4975/4501 (no Ψ4501)                             18S-918/28S-4501 (no Ψ4501)              SNORA22 can modify 4501 in artificial RNA substrate, yet actual modified position in 28S is Ψ4502, not 4501[^c^](#tblfn3){ref-type="table-fn"}   
  SNORA25                                      18S-801                                                      18S-801                                  18S-801                                                                                                                                          Modification mapping in different species
  18S-814/28S-4597                             ---                                                          28S-4558 (amphibians, reptiles, birds)   Tested in yeast cell system                                                                                                                      
  SNORA29[^d^](#tblfn4){ref-type="table-fn"}   28S-4492[^e^](#tblfn5){ref-type="table-fn"}                  28S-45 (no Ψ in human)                   28S-45 (all, except human)                                                                                                                       Modification mapping in different species, northern blot analysis of SNORA29 expression
  18S-220                                      18S-220 (no Ψ in human)                                      18S-220 (all, except human)                                                                                                                                                               
  SNORA35                                      18S-566                                                      Orphan                                   18S-566 (amphibians, reptiles)                                                                                                                   Modification mapping in different species
  U7-7                                         18S-350 (all, C in mammals)                                                                                                                                                                                                                            
  SNORA49                                      28S-2826                                                     28S-2826                                 28S-2826                                                                                                                                         Modification mapping in different species
  28S-2830                                     28S-2830                                                     --- (28S-2830 in birds)                                                                                                                                                                   
  SNORA57                                      18S-1004                                                     18S-1004                                 18S-1004                                                                                                                                         Modification mapping in different species
  18S-1046                                     18S-1045/1046                                                18S-1045/1046                            Tested in yeast cell system                                                                                                                      
  SNORA61                                      28S-2495                                                     28S-2495                                 28S-2495                                                                                                                                         Tested in yeast cell system
  18S-918                                      18S-918                                                      18S-918                                                                                                                                                                                   
  SNORA63                                      ---                                                          28S-4491                                 28S-4491                                                                                                                                         *Xenopus* SNORA10 lacks antisense element for 28S-Ψ4491, but the modification is mediated by SNORA63
  28S-4390                                     28S-4390                                                     28S-4390                                                                                                                                                                                  

Positions are numbered based on reference human sequences.

Compiled from: [https://www-snorna.biotoul.fr//index.php](https://www-snorna.biotoul.fr//); last accessed August 16, 2019 (Lestrade and Weber [@msz209-B34]), <http://www.bioinf.uni-leipzig.de/publications/supplements/12-022>; last accessed August 16, 2019 ([@msz209-B29]), <http://snoatlas.bioinf.uni-leipzig.de>; last accessed August 16, 2019 ([@msz209-B24]).

Position 4501 in human 28S rRNA was mistakenly annotated as pseudouridine in the original article ([@msz209-B44]); the actual modified position was 4502; the corresponding pseudouridine was correctly numbered in mouse 28S rRNA.

Mature SNORA29 is not expressed in human.

This prediction resulted from a misprint in [@msz209-B29]. The correct prediction is 28S-45.

Among *Xenopus* snoRNAs that showed no homology with any known snoRNAs, we found three box H/ACA RNAs for other highly conserved modifications in snRNAs and 18S rRNA; these modified positions have no guide RNAs assigned so far in any other species, including human ([supplementary table 1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online, highlighted in red). These new snoRNAs are pseudouridylation guide RNAs for position 6 in U2 snRNA, position 12 in U4atac snRNA, and 2′-*O*-methylated U1288 in *Xenopus* 18S rRNA (equivalent to Ψm1326 in human 18S rRNA). The existence of these guide RNAs was verified by RACE (rapid amplification of cDNA ends) and northern blot analysis. We previously described a *Xenopus* guide RNA for positioning conserved Ψ43 in U2 snRNA ([@msz209-B11]). So far, we have not found corresponding guide RNAs in human and other genome assemblies based on sequence and structure similarity.

Intriguingly, five other *Xenopus*-specific snoRNAs show complementarity with 18S rRNA, at positions that have never been reported as modified in any vertebrate species; four additional *Xenopus*-specific snoRNAs were assigned to unexpected positions in 28S rRNA and U6 snRNA ([supplementary table 1](#sup1){ref-type="supplementary-material"}, highlighted in green; [supplementary fig. 1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Furthermore, in 21 evolutionarily conserved snoRNAs we predicted additional antisense elements for positioning modifications in 18S, 28S, and 5.8S rRNAs at unexpected positions ([figs. 2](#msz209-F2){ref-type="fig"}--[7](#msz209-F7){ref-type="fig"}, [supplementary figs. 1 and 3](#sup1){ref-type="supplementary-material"} and [supplementary table 1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). The majority of these antisense elements were found in *Xenopus* snoRNAs but not in human homologs. At the same time, at least ten antisense elements identified in human snoRNAs are missing from the homologous *Xenopus* snoRNAs ([fig. 8](#msz209-F8){ref-type="fig"} and [supplementary table 1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). These findings made us curious about the existence of modifications at the predicted positions in rRNAs from different vertebrate species.

![An evolutionarily conserved snoRNA cluster hosted by the *TAF1D* locus. (*A*) Schematic drawing of *TAF1D* gene models in different vertebrate species. Homologous intron-encoded snoRNAs are color-coded. (*B*) Predicted base-pairing between 18S rRNA and *Xenopus*-specific snoRNA pug18S-211. (*C*) Clustal analysis of SNORA25 sequences from different species. Those that have two functional pseudouridylation pockets are highlighted with stars. Predicted interactions with rRNAs are shown for the 3′ terminal domains of SNORA25 from human, *Xenopus*, chicken, lizard and alligator. Strong base-pairing of human SNORA25 with 18S rRNA for positioning Ψ814 is possible only in a highly unstable configuration. For experimental verification of the predicted guide activities, see supplementary figures 3*A* and 4, [Supplementary Material](#sup1){ref-type="supplementary-material"} online. (*D*) Predicted base-pairing between SNORA40 and rRNAs: An alternative configuration for positioning of pseudouridine in 28S rRNA is functional in human but not in *Xenopus*.](msz209f3){#msz209-F3}

![(*A*) Expression of the SNORA10/SNORA64 snoRNA family. Insertions of transposable elements (indicated with red triangles) destroyed SNORA10 in rodents and bats. No SNORA10 sequences were found in fish (except *Latimeria*) and chicken. In mammalian species SNORA10 gave rise to SNORA64, targeting 28S rRNA at position 4975. (*B*) Postulated base-pairing between SNORA10 and rRNAs: human SNORA10 targets 18S-210 and 28S-4491, whereas *Xenopus* SNORA10 targets 5.8S rRNA instead of 28S rRNA. SNORA63 is a newly identified conserved guide RNA for positioning 28S-Ψ4491. SNORA64 and SNORA22 can modify human 28S rRNA at position 4975. The equivalent position in *Xenopus* is not modified, because SNORA22 interaction with *Xenopus* 28S rRNA is weak, and SNORA64 is not expressed in nonmammalian species.](msz209f4){#msz209-F4}

![(*A*) Postulated base-pairing between SNORA29 and 28S rRNA (H-box domain) and 18S rRNA (ACA-box domain). The canonical ACA box is characteristic of SNORA29 in all nonhuman vertebrates that have been analyzed. A point mutation in the human SNORA29 sequence is shown in magenta. We found the same A-to-G substitution in the Neandertal and Denisovan genomes (<https://genome.ucsc.edu/Neandertal/>; last accessed August 16, 2019). Pseudouridylation of 28S rRNA at position 45 and of 18S rRNA at position 220 was not detected in human RNA samples (see [supplementary fig. 4](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). (*B*) Northern blot analysis of total RNA isolated from mouse 3T3 and human HeLa cells with a probe specific for the human SNORA29 sequence. Mature SNORA29 was detected in mouse RNA samples, but not in human. Amount of RNA loaded on the gel is indicated at the top of each lane. 5S rRNA served as a loading control.](msz209f5){#msz209-F5}

![(*A*) The SNORA16 snoRNA family includes *Xenopus*-specific SNORA16-like guide RNA pug18S-137 clustered together with SNORA16 from diverged vertebrate species. (*B*) *Xenopus* SNORA16-like pug18S-137 arose from an additional copy of SNORA16 encoded within the nonprotein-coding *SNHG12*, which harbors a conserved snoRNA cluster; conserved snoRNAs in this cluster are indicated and color-coded. (*C*) Postulated base-pairing between evolutionarily conserved SNORA16 and 28S rRNA and between *Xenopus*-specific SNORA16-like and 18S rRNA.](msz209f6){#msz209-F6}

![(*A*) The SNORA58 snoRNA family includes *Xenopus*-specific SNORA58-like guide RNA pug18S-324 clustered together with SNORA58 from diverged vertebrate species. Zebrafish snoRNA (top line marked with two stars), although similar in sequence to other SNORA58s, does not have the conserved pseudouridylation pocket for positioning pseudouridine in 28S rRNA. (*B*) *Xenopus* SNORA58 and SNORA58-like RNAs are encoded in the evolutionarily conserved SNORA58 host gene *UBAP2L.* (*C*) Postulated base-pairing between evolutionarily conserved SNORA58 and 28S rRNA and between *Xenopus*-specific SNORA58-like and 18S rRNA.](msz209f7){#msz209-F7}

![Antisense element shuffling between conserved snoRNA families in *Xenopus* and human. When a family is represented by multiple copies of snoRNAs with diverged antisense elements, all such variants are depicted. Identical and/or diverged antisense element targets are color-coded. The actual target positions and snoRNA copy numbers are listed in [supplementary table 1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online.](msz209f8){#msz209-F8}

rRNA Modification in Vertebrate Species
---------------------------------------

rRNA modification mapping is often regarded as a completed story. In fact, rRNA modifications were mostly studied in budding yeast *S.* *cerevisiae* and human ([@msz209-B41]; [@msz209-B40]; [@msz209-B5]; [@msz209-B33]; [@msz209-B59], [@msz209-B58]; [@msz209-B52]). Although 2′-*O*-methylated positions were meticulously mapped in both human and *X. laevis* 18S rRNA ([@msz209-B38]), only eight pseudouridines have been mapped so far more or less precisely in *X. laevis* 18S rRNA ([@msz209-B48]; [@msz209-B38]; [supplementary fig. 4](#sup1){ref-type="supplementary-material"}*A*, highlighted in gray, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). The total number of pseudouridines in *X. laevis* 18S rRNA was estimated to be between 45 and 49 ± 2 ([@msz209-B20]; [@msz209-B43]). *Xenopus* *tropicalis* rRNAs have never been examined for modifications. Therefore, we decided to map pseudouridines and 2′-*O*-methylated residues in both 18S rRNA and most of 28S rRNA from *X. tropicalis* and *X. laevis*; human rRNAs served as a control. In addition, we examined pseudouridylation patterns of 18S rRNA in six other species from different vertebrate classes: newt *Notophthalmus viridescens* and axolotl *Ambystoma mexicanum* (Amphibia), mouse *Mus musculus* (Mammalia), domestic chicken *Gallus gallus* (Aves), Mexican whiptail lizard *Aspidoscelis neomexicana* (Reptilia), and zebrafish *Danio rerio* (Teleostei). All modifications detected in 18S rRNA from nine vertebrate species are compiled in [figure 9](#msz209-F9){ref-type="fig"} and [supplementary figure 4](#sup1){ref-type="supplementary-material"}*A*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online. We found five pseudouridines that were recently identified in human 18S rRNA to be highly conserved: Ψ256, Ψ1045, Ψ1046, Ψ1177, and Ψ1232 ([@msz209-B24]; [@msz209-B58]). They have been detected unequivocally in all analyzed species ([supplementary fig. 4](#sup1){ref-type="supplementary-material"}*A*, highlighted in yellow, [Supplementary Material](#sup1){ref-type="supplementary-material"} online).

![Graphical representation of comparative pseudouridylation analysis of 18S rRNA from nine vertebrate species and yeast *Saccharomyces cerevisiae*. All positions that contain pseudouridine in at least one species are highlighted.](msz209f9){#msz209-F9}

It is worth emphasizing that *Xenopus*-specific snoRNAs we identified and assigned to unexpected positions in 18S and 28S rRNAs coincide with corresponding modifications in *X. tropicalis* and *X. laevis* rRNAs, but not in human. Also, we found modifications at unexpected positions assigned to novel antisense elements in *Xenopus* snoRNAs from conserved snoRNA families. Again, these modifications exist in *Xenopus* but not in human ([supplementary fig. 4](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). At the same time, at least 14 snoRNAs identified in human are not expressed in *X. tropicalis.* Additionally, as mentioned above, ten human snoRNAs from highly conserved snoRNA families contain antisense elements missing from *Xenopus* orthologs ([fig. 8](#msz209-F8){ref-type="fig"}). This resulted in the absence of 17 modifications in *Xenopus* rRNAs as compared with human. Modification patterns in other vertebrate species may vary; nonetheless, these patterns generally correlate with corresponding snoRNA modification activities ([supplementary fig. 4](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online).

Gain and Loss of snoRNA Modification Activities in Vertebrates
--------------------------------------------------------------

Although many eukaryotic snoRNAs show evolutionary conservation, a number of mammalian snoRNAs cannot be traced to ancestral snoRNA families. Similarly, several snoRNAs identified in *Xenopus* have no relationship to any known snoRNAs in other organisms. Furthermore, their expression might be limited to frogs, for example, pug*xt*18S-211 encoded in an intron of *Taf1d* harboring multiple conserved snoRNAs ([fig. 3*A* and *B*](#msz209-F3){ref-type="fig"}) or only to the genus *Xenopus*, for example, pug*xt*18S-124 hosted by the *Rpl26* gene. Although *xt*pug18S-211 provides a clear example of gain of modification through acquisition of both novel intron and intronic snoRNA in a frog-restricted manner, pug*xt*18S-1279 found in an intron of the *Rpl35* gene represents a novel evolutionarily conserved snoRNA. The corresponding snoRNA sequences and 18S rRNA pseudouridilation at the equivalent position are evident in frogs, lizard, and zebrafish ([supplementary figs. 1 and 4*A*](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). The expression of pug18S-1279 homologs in these species also coincides with an additional intron in the *Rpl35* gene. This intron seems to be lost along with the snoRNA in mammals and birds. The loss of pug18S-1279 is accompanied by the U-to-C change in 18S rRNA ([supplementary fig. 4](#sup1){ref-type="supplementary-material"}*A*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online).

Another mechanism for loss of snoRNA function is a transposable element insertion. That is how SNORA10 was destroyed in rodents and bats ([fig. 4*A*](#msz209-F4){ref-type="fig"}). The loss of SNORA10 expression led to loss of pseudouridylation of 18S rRNA at position 210 ([supplementary fig. 4](#sup1){ref-type="supplementary-material"}*A*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online), which coincided with the U-to-C transition at the corresponding position in some species ([fig. 4*A*](#msz209-F4){ref-type="fig"}). SNORA10 was identified also as a guide for 28S rRNA pseudouridylation at the position corresponding to human 4491 ([fig. 4*B*](#msz209-F4){ref-type="fig"}). However, we did not observe the loss of this modification in the absence of SNORA10 expression. Furthermore, the *Xenopus* SNORA10 sequence is slightly diverged; that is, this snoRNA targets 5.8S rRNA instead of 28S rRNA ([fig. 4*B*](#msz209-F4){ref-type="fig"}), yet modification of 28S rRNA is not affected in *Xenopus* either. In our target prediction analysis, we identified an additional antisense element for positioning 28S-Ψ4491 within an orphan pseudouridylation pocket of SNORA63 ([fig. 4*B*);](#msz209-F4){ref-type="fig"} this antisense element is highly conserved evolutionarily, explaining the persisting pseudouridylation of 28S rRNA in the absence of SNORA10 activity.

Large genomic changes are not necessary for snoRNA distortion. Primary sequences homologous to SNORA75 are almost identical in two *Xenopus* species. The SNORA75 coding sequence in *X. laevis* has a short 10-nt deletion in the upper loop of the 5′-terminal domain compared with *X. tropicalis*; otherwise the sequences align with more than 82% identity, including conserved H/ACA boxes, antisense element sequence, and overall secondary structure. Nevertheless, SNORA75 is not expressed in *X. laevis*, which results in the absence of 18S-Ψ93 ([supplementary fig. 4](#sup1){ref-type="supplementary-material"}*A*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). SNORA29 expression in human is even more compelling. In this snoRNA, we predicted antisense elements for position 45 in 28S rRNA and position 220 in 18S rRNA; the latter position was also predicted by [@msz209-B24]. The sequence of this snoRNA is highly conserved cross-species ([fig. 5*A*);](#msz209-F5){ref-type="fig"} however, the predicted modifications are evident in *Xenopus* and other amphibians, lizard, chicken, and mouse, but they have never been detected in human, both in our experiments ([supplementary fig. 4](#sup1){ref-type="supplementary-material"}*A* and *B*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online) and other studies ([@msz209-B5]; [@msz209-B54]; [@msz209-B58]). Despite the fact that SNORA29 was originally identified in HeLa cells ([@msz209-B32]), we could not detect processed SNORA29 in human fibroblasts and HeLa cell lines by 5′- and 3′-RACE or by northern blot analysis ([fig. 5*B*](#msz209-F5){ref-type="fig"}). The only structural difference that discriminates the human SNORA29 coding sequence from other primate species and various vertebrates is a point mutation at the box ACA ([fig. 5*A*](#msz209-F5){ref-type="fig"}). Thus, this mutation presumably causes misprocessing of human SNORA29 and loss of evolutionarily highly conserved modifications in one particular species.

Orphan Domains in snoRNAs Find Their Targets
--------------------------------------------

As we mentioned above, several evolutionarily conserved snoRNAs in *Xenopus* contain antisense elements specific to positions in rRNAs that are not modified in mammals. We will describe three notable examples of gain and loss of guide activity in functional domains of snoRNAs during evolution.

SNORA14 provides an example of a conserved snoRNA that has lost its modification activity on rRNA at a highly conserved region. In all vertebrate species, the 3′-terminal domain of this snoRNA targets position 966 in 18S rRNA for pseudouridylation. At the same time, only in amphibians and zebrafish does the 5′-terminal domain form a pseudouridylation pocket that specifically modifies 18S rRNA at the position equivalent to human U892 ([supplementary fig. 3](#sup1){ref-type="supplementary-material"}*B*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Furthermore, in *Xenopus* the 5′-terminal pseudouridylation pocket is invariably present in all five copies of this snoRNA, even though one of these copies does not contain the conserved antisense element in the 3′-terminal domain. Yet in reptiles, birds, and mammals, the 3′-terminal antisense element, but not the 5′-terminal antisense element, remains preserved. Importantly, *Xenopus* SNORA14, when expressed exogenously from a plasmid, was able to modify the corresponding positions in yeast ([supplementary fig. 3](#sup1){ref-type="supplementary-material"}*A*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online) and human 18S rRNA ([@msz209-B13]). That is, the corresponding position of 18S rRNA is promiscuous for pseudouridylation, yet the ability to modify this position has been lost in reptiles, birds, and mammals.

SNORA25 shows gain and loss of modification activity of one pseudouridylation pocket, whereas the activity of the other pocket remains preserved during evolution ([fig. 3*C*](#msz209-F3){ref-type="fig"}). When this snoRNA was first identified in human RNA, it was annotated as a guide RNA for positions 801 and 814 in 18S rRNA ([@msz209-B32]). Based on our analysis, the 3′-terminal domain of human SNORA25 does not form a structurally stable pseudouridylation pocket for positioning of 18S-Ψ814 ([fig. 3*C*](#msz209-F3){ref-type="fig"}) and, accordingly, this snoRNA could not modify the corresponding position in yeast ([supplementary fig. 3](#sup1){ref-type="supplementary-material"}*A*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Thus, we exclude 18S-814 from potential SNORA25 targets, which leaves no target assigned to the 3′-terminal domain of human SNORA25. However, in *Xenopus*, reptile, and chicken SNORA25 orthologs, the 3′-terminal domain contains an antisense element that targets a position equivalent to 4558 in human 28S rRNA ([fig. 3*C*](#msz209-F3){ref-type="fig"}). We found pseudouridine at this position in four amphibian species, lizard and chicken as expected, but not in mammals and fish ([supplementary fig. 4](#sup1){ref-type="supplementary-material"}*B*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online).

SNORA35 is an even more intriguing example of loss of modification activity. This highly conserved orphan box H/ACA snoRNA has a predicted antisense element for position 566 in human 18S rRNA ([@msz209-B24]), yet no pseudouridine has been detected in human and mouse ([@msz209-B5]; [@msz209-B54]; [@msz209-B58]; our data). The equivalent position, however, is pseudouridylated in the four amphibian species and the lizard we tested ([supplementary fig. 4](#sup1){ref-type="supplementary-material"}*A*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Furthermore, in all species except mammals, SNORA35 also targets position 350 for pseudouridylation ([fig. 2](#msz209-F2){ref-type="fig"}); mammalian 18S rRNA has a C at this position ([supplementary fig. 4](#sup1){ref-type="supplementary-material"}*A*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Thus, in nonmammal species, SNORA35 is a guide for 18S rRNA pseudouridylation, but in mammals it is well-preserved and still remains "orphan," despite the loss of function on 18S rRNA.

Target Switch by Point Mutations
--------------------------------

The comparative analysis of human and *Xenopus* snoRNA functions revealed a substantial number of differences in snoRNAs and corresponding modifications between these two species ([fig. 8](#msz209-F8){ref-type="fig"} and [supplementary table 1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Typically, novel modifications are associated with newly acquired snoRNAs and significantly diverged copies of preexisting or recently duplicated snoRNA sequences. These diverged snoRNAs with different targets show some similarities and are usually grouped in families, such as the SNORA10/SNORA64 or SNORA2/SNORA34 families. Thus, mammalian SNORA64 must be derived from a recently duplicated ancestral SNORA10, whereas a preexisting copy of SNORA2 gave rise to SNORA34. Notably, human SNORA34 shows more similarity to both copies of *Xenopus* SNORA2 (54% and 55% identity) than to a human copy of SNORA2 (46% identity). Although this moderate or low level of similarity is quite common for snoRNA families with diverged substrate specificities, we argue here that such a significant sequence divergence is not required for a distinctive change in substrate recognition. Even a single nucleotide difference can convert a fully functional snoRNA (or a particular antisense element) into a nonfunctional copy or can completely change its modification guide specificity.

When we identified the *Xenopus* SNORD69 sequence and performed a comparative analysis of target predictions for it and SNORD19 from different vertebrate species, we found dual-guide modification activities for all SNORD19s and for SNORD69 from *Xenopus* and fish: namely, 2′-*O*-methylation of 28S rRNA at the position corresponding to human G4464 and of 18S rRNA at the position corresponding to human G683 ([fig. 1*E*](#msz209-F1){ref-type="fig"}). Our analysis allowed us to group SNORD19 and SNORD69 in an snoRNA family, both having originated from the same ancestral snoRNA by duplication and divergence. Essentially, *Xenopus* SNORD69 clusters with SNORD69 sequences from other species ([fig. 1*D*](#msz209-F1){ref-type="fig"}), yet it differs functionally. That is, a single nucleotide difference between SNORD69 antisense elements from different species led to the loss of modification guide activity on 18S rRNA in reptiles, birds, and mammals ([fig. 1*E*](#msz209-F1){ref-type="fig"}, star). Two other examples of highly conserved snoRNAs having their target specificities changed by point mutations are *Xenopus* SNORA16 and SNORA58, which gave rise to pug18S-137 and pug18S-324, respectively ([figs. 6 and 7](#msz209-F6){ref-type="fig"}). These novel modification guide RNAs cluster indistinguishably with other members of the families from which they originated. Thus, these data clearly demonstrate that snoRNA sequence conservation is not necessarily indicative of functional conservation.

Another intriguing case is SNORA28. This highly conserved snoRNA is a well-characterized guide RNA for two pseudouridines in 18S rRNA, 18S-Ψ815 and 18S-Ψ866 ([@msz209-B32]; [@msz209-B66]). Although 18S-Ψ815 was detected in all vertebrate species we analyzed, pseudouridylation at the position equivalent to 866 varied between species. Even the closely related frogs, *X. laevis* and *X. tropicalis*, showed differential modification at this position ([supplementary fig. 4](#sup1){ref-type="supplementary-material"}*A*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Remarkably, both copies of *X. laevis* SNORA28 have point mutations in the antisense element for positioning 18S-Ψ866 ([supplementary fig. 3](#sup1){ref-type="supplementary-material"}*B*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). One of these copies has only a single nucleotide mismatch and exhibits modification guide activity on the appropriate artificial substrate RNA ([supplementary fig. 3](#sup1){ref-type="supplementary-material"}*C*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online), but cannot induce pseudouridylation of endogenous 18S rRNA when tested in a yeast cell system ([supplementary fig. 3](#sup1){ref-type="supplementary-material"}*A*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). It is worth noting that both yeast and *X. laevis* 18S rRNAs are promiscuous for pseudouridylation at the position equivalent to human 18S-Ψ866. When *X. tropicalis* SNORA28 was expressed in yeast ([supplementary fig. 3](#sup1){ref-type="supplementary-material"}*A*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online) or in the *X. laevis* XTC cell line ([@msz209-B13]), 18S rRNA was efficiently modified at the expected position. Why some modifications are stabilized or lost only in particular species within a taxon is an open question.

Point mutations in substrate RNAs also contribute to the generation of functional antisense elements within a conserved snoRNA to target a novel position for modification. In fact, a single U-to-A mutation in human SNORA40 accompanied by a C-to-U substitution in 28S rRNA resulted in the formation of 28S-Ψ4546 in human. However, the equivalent position in *Xenopus* is unmodified ([supplementary fig. 4](#sup1){ref-type="supplementary-material"}*B*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Instead, as we mentioned earlier, the position equivalent to human 4558 is modified by SNORA25 in amphibians, reptiles, and birds, but not in mammals. Notably, the mutation in human SNORA40 that introduces a new 28S rRNA substrate specificity does not affect modification activity of the same pseudouridylation pocket at the highly conserved position in 18S rRNA ([fig. 3*D*](#msz209-F3){ref-type="fig"} and [supplementary fig. 4](#sup1){ref-type="supplementary-material"}*A*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online).

Human SNORA22 illustrates many of the same issues. It was originally annotated as a guide RNA for 28S rRNA: Its 5′- and 3′-terminal domains were predicted to guide 28S-Ψ4966 ([@msz209-B32]) and 28S-Ψ4975 ([@msz209-B49]), respectively. We find that the 5′-terminal antisense element is weak for positioning of 28S-Ψ4966. When tested in yeast, SNORA22 did not mediate pseudouridylation of an artificial substrate RNA corresponding to 28S-Ψ4966 ([supplementary table 2](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online); that is, SNORA33, but not SNORA22 is the genuine guide RNA for this modification. As for the 3′-terminal domain, we determined that SNORA22 could mediate pseudouridylation at position 4975 of human 28S RNA, but not at the equivalent position of *Xenopus* 28S rRNA. This activity occurred despite the unusually long distance from the ACA box to the target uridine (18 nt). The corresponding sequence in *Xenopus* 28S rRNA generates an additional noncanonical U--G base pair between SNORA22 and 28S rRNA ([fig. 4*B*](#msz209-F4){ref-type="fig"}). In our guide activity assay using cultured vertebrate cells, the human-specific substrate RNA became modified when expressed in both human (HeLa) and *Xenopus* (XTC) cell lines. At the same time, the *Xenopus*-specific substrate RNA became modified only in HeLa cells ([supplementary table 2](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Importantly, endogenous *Xenopus* 28S rRNA is not pseudouridylated at the position equivalent to human 4975. How can we interpret these results? In mammals, SNORA64 is an additional guide RNA for this position ([fig. 4*B*](#msz209-F4){ref-type="fig"}). This is a diverged copy of SNORA10 that is missing in nonmammalian species. Nonetheless, both human and *Xenopus*-specific sequences of 28S rRNA are good substrates for human SNORA64 ([fig. 4*B*](#msz209-F4){ref-type="fig"}). Thus, a single G-to-A substitution in 28S rRNA in mammals generated a good substrate for a preexisting pseudouridylation pocket in SNORA22. Somehow this novel pseudouridine became beneficial, and mammals acquired an additional better guide RNA for the same position, SNORA64. It is worth noting that the position in *Xenopus* equivalent to human 28S-5011 is modified instead of 4975; the corresponding guide RNA pug*xt*28S-4066 has been identified in our snoRNA search ([supplementary table 1](#sup1){ref-type="supplementary-material"} and [supplementary fig. 1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). The recently annotated SNORA100 was predicted to modify 28S-5011 in human and mouse ([@msz209-B37]). However, we could not detect expression of this snoRNA in either species. Moreover, modification itself has not been detected in these species ([@msz209-B54]; [@msz209-B58]; our data). These observations make us propose that the so-called SNORA100 is an snoRNA-like sequence representing a remnant of the actual guide RNA identified in *Xenopus*.

Recently, the 3′-terminal domain of SNORA22 and the 5′-terminal domain of SNORA61 were predicted to mediate pseudouridylation of position 918 in human 18S rRNA and the equivalent position in other species ([@msz209-B29]; [@msz209-B24]; our predictions). For a long time, this highly conserved modification had no assigned guide RNA. Because the binding affinity of snoRNAs with 18S rRNA is not very strong ([supplementary fig. 1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online), we urge that predicted modification guide activities be tested experimentally. We expressed human and *Xenopus* SNORA22 and SNORA61 in yeast cells and observed the predicted pseudouridylation in an artificial substrate RNA that contained the corresponding fragment of human 18S rRNA ([supplementary table 2](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). These tests verified that SNORA22 and SNORA61 are genuine pseudouridylation guide RNAs for 18S rRNA. Remarkably, despite the relatively weak binding affinity of these snoRNAs with 18S rRNA, this guide activity is evolutionarily conserved in vertebrate SNORA22.

Thus, our data clearly demonstrate that miniscule changes in an antisense element may result in loss or gain of snoRNA modification guide activity, even when overall sequence conservation is preserved. Furthermore, 5′- and 3′-terminal domains in snoRNAs may evolve independently. Thus, one domain may remain intact during evolution whereas the other gains a novel modification activity or loses a conserved function. These events can even occur in a single species. We stress that careful target predictions and experimental verifications are essential steps in studies of snoRNA evolution.

Discussion
==========

Previous evolutionary studies of snoRNAs focused mostly on the conservation and ancestral tracing of these RNAs ([@msz209-B17]; [@msz209-B29]). The analysis of modification guide RNA specificities was carried out primarily on human snoRNAs (Lestrade and Weber [@msz209-B34]; [@msz209-B24]). In this study, we performed modification target prediction analysis independently on snoRNA sets from two diverged species: human and the frog *X. tropicalis*. Then, we compared our functional predictions across species. This approach allowed us to identify novel antisense elements in *Xenopus* snoRNAs from highly conserved snoRNA families; these antisense elements were predicted to target unexpected positions in rRNAs. Furthermore, we found several novel *Xenopus* snoRNAs that also target unusual positions in rRNAs and U6 snRNA ([supplementary table 1](#sup1){ref-type="supplementary-material"} and [supplementary fig. 1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Three such nonmammalian box C/D snoRNAs had been identified earlier, but the assigned novel modifications had never been verified ([@msz209-B42]). We performed RNA modification mapping and found the predicted modifications in *Xenopus*, but not in human. Similarly, at least 14 snoRNAs are expressed in human but are absent in *X. tropicalis*, including nine unmodified positions in *Xenopus* rRNAs. In addition, ten highly conserved human snoRNAs contain antisense elements missing from *Xenopus* ([fig. 8](#msz209-F8){ref-type="fig"}), resulting in nine additional modifications detected in human but not in *Xenopus*. Our interspecies analysis thus questions the evolutionary conservation of snoRNAs and the posttranscriptional modifications they mediate. An earlier bioinformatic analysis of fungal snoRNAs also revealed extensive lineage-specific gain and loss of entire snoRNA families and specific guide functions during fungal evolution ([@msz209-B4]).

The evolutionarily stable association of snoRNAs with their host genes has been emphasized in mammalian genomic studies ([@msz209-B18]). However, snoRNA distribution does not show perfect synteny between more diverged organisms. For instance, only one-third of orthologous chicken and human host genes have orthologous snoRNA sequences in the same introns and in the same order ([@msz209-B51]). Extending this analysis to *Xenopus* and other vertebrates, we always find differences between taxa in snoRNA order, position in a particular intron, and specific snoRNA family members within orthologous host genes ([figs. 1*A*, 3*A*, 4*A*, 6*B*, and 7*B*](#msz209-F1){ref-type="fig"}). In addition, there are more snoRNA copies in *Xenopus* than in human ([supplementary table 1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). A smaller number of gene copies was previously reported for box C/D snoRNAs in placental mammals ([@msz209-B42]), and we find the same trend for H/ACA snoRNAs. Thus, over evolutionary time snoRNA sequences move from intron to intron within the same gene and between different genes. The most plausible mechanisms for these intra- and intergenic snoRNA movements are recombination, segmental duplication, and retrotransposition. All of these mechanisms seem to be exploited ([@msz209-B64]; [@msz209-B51]; [@msz209-B17]).

It is usually postulated that modifications in snRNAs and rRNAs are highly conserved. It is true that the majority of pseudouridylated and 2′-*O*-methylated positions concentrate in highly conserved and functionally important regions ([@msz209-B26]; [@msz209-B58]), but the specific modified positions within these regions may vary in different species. When we analyzed the pseudouridylation patterns of 18S rRNA from nine vertebrate species, we found that only half of the detected pseudouridines were present in all species (30 out of 57 positions; [fig. 9](#msz209-F9){ref-type="fig"} and [supplementary fig. 4](#sup1){ref-type="supplementary-material"}*A*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Undoubtedly, such variation is common and more examples will be found when additional species are analyzed. We also noticed that loss of pseudouridylation activity was sometimes accompanied by an U-to-C transition at the corresponding position ([fig. 9](#msz209-F9){ref-type="fig"} and [supplementary fig. 4](#sup1){ref-type="supplementary-material"}*A* and *B*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Although the ability of pseudouridine to base-pair with other bases is similar to that of uridine ([@msz209-B53]), when modified RNA passes through the nanopore of an Oxford Nanopore sequencing device, pseudouridine induces the same or very similar current fluctuation as cytosine ([supplementary fig. 4](#sup1){ref-type="supplementary-material"}*C*, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). This finding suggests that the U-to-C transition plays a compensatory role in the absence of pseudouridylation, and that pseudouridine has an additional hidden feature of structural importance. In our comparative analysis of RNA modifications, we were struck by unpredicted differences between closely related species. How can we explain the loss of SNORA29 and two highly conserved pseudouridines, 18S-Ψ220 and 28S-Ψ45 only in human? Why do two pseudouridines positioned by SNORA28 and SNORA75 exist in *X. tropicalis* 18S rRNA but not in *X. laevis*? One possibility is that those pseudouridines play a role in temperature adaptation. Heat shock-inducible pseudouridines have been detected in yeast and human RNAs, U2 snRNA ([@msz209-B65]), and numerous mRNAs ([@msz209-B5]; [@msz209-B35]; [@msz209-B50]; [@msz209-B25]). Accordingly, the *X. tropicalis* habitat (23--28 °C) correlates with a higher level of pseudouridylation of rRNA ([fig. 9](#msz209-F9){ref-type="fig"}) compared with that of *X. laevis* (16--22 °C), axolotl (12--20 °C), and newt (21 °C). In support of this hypothesis, the recent study of pseudouridines in *Trypanosoma brucei* found higher level of pseudouridylation in the bloodstream form of the parasite, which develops at elevated temperatures, compared with the procyclic form ([@msz209-B47]). Thus, the adaptive role of RNA modification at certain positions could explain some unexpected differences in modification patterns between evolutionarily close but environmentally diverged species.

Another common notion is that conserved snoRNAs target orthologous sites for modification ([@msz209-B17]; [@msz209-B45]), especially in vertebrates ([@msz209-B29]). Indeed, about 73% of orthologous box C/D snoRNAs contain antisense elements that are well preserved from *Xenopus* to human. However, only 39% of box H/ACA snoRNAs are functionally conserved in the sense that homologous snoRNAs from different species possess antisense elements for modification of orthologous positions ([supplementary table 1](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online). Furthermore, these numbers could be lower if we consider orphan domains in snoRNAs. Their unassigned potential antisense element sequences often vary significantly in different species. The usual assumption is that these highly diverged sequences do not experience any selective pressure because they are nonfunctional. Alternatively, they may mediate modification of nonorthologous positions in diverged RNA molecules. In support of this postulate, we identified genuine modification guide activities in conserved snoRNAs, which were previously thought to contain orphan domains. In many cases, these guide activities are species or taxon-specific. In addition, certain modification guide activities at orthologous positions may shuffle between nonorthologous snoRNAs. These are not rare or exceptional cases ([fig. 8](#msz209-F8){ref-type="fig"}). We postulate that each domain within a particular snoRNA can evolve independently as a functional unit. It has been shown experimentally that an individual H-box or ACA-box stem upstream of a box C/D RNA sequence produces a stable RNA molecule ([@msz209-B3]). Furthermore, stable single-domain box H/ACA RNAs, namely AluACA RNAs, have been identified in human ([@msz209-B22]). Single hairpin pseudouridylation guide RNAs exist in Archaea ([@msz209-B7]) and are typical for trypanosomes ([@msz209-B47]). The same is true for one half of a box C/D snoRNA ([@msz209-B31]; [@msz209-B61]; [@msz209-B46]; our unpublished data).

Additionally, functional conservation of homologous snoRNAs is somewhat overestimated due to lack of experimental verification of predicted guide RNA modification activities. In most eukaryotic species, except for yeast, snoRNA substrate assignment is based on computational analysis and sequence complementarity predictions. Only a few of the predicted interactions have been experimentally tested so far ([@msz209-B62][@msz209-B63]; [@msz209-B23]; [@msz209-B70]; [@msz209-B9], [@msz209-B10], [@msz209-B11], [@msz209-B12]; [@msz209-B66]; [@msz209-B46]). Our data clearly demonstrate that even a single nucleotide change may result in the generation of a novel antisense element in a highly conserved snoRNA and consequently induce a novel modification. Likewise, a one-nucleotide mismatch within a conserved antisense element may convert a functional domain into a nonfunctional one ([@msz209-B12][@msz209-B13]; this study). At the same time, some snoRNAs with weak antisense elements were found fully functional when they were tested experimentally ([@msz209-B10], [@msz209-B11], [@msz209-B12]; this study). That is, almost identical paralogous and orthologous snoRNAs, even when they cluster together and can be traced to a common ancestor, can function completely differently. Thus, the functional identity of snoRNAs from different species cannot be deduced from sequence conservation alone, but must be demonstrated directly by functional assays.

Our data discussed so far demonstrate that RNA modification patterns and snoRNA guide activities are more adaptable than is often assumed. Nevertheless, many snoRNAs show exceptional conservation across different taxa in their modification guide activities and/or in their genomic positions, being encoded in orthologous host genes and grouped there with the same sets of other snoRNAs. Examples include the well-characterized guide RNAs for multiple positions in the heavily modified branch point recognition region in spliceosomal U2 snRNA or for two adjacent positions in the 5′-terminal loop of U5 snRNA: SCARNA8, SCARNA15, SCARNA10. The conservation of these RNAs is evident in both vertebrate and invertebrate species. These combinations of multiple activities in one guide RNA prevent interference between different modified positions during the modification process ([@msz209-B12]). Similarly, evolutionarily well-preserved snoRNA clusters might be essential to regulate coordinated expression of functionally interconnected snoRNAs. Notably, when mammalian SNORA25 lost its 28S rRNA specificity, a "compensatory" guide activity on the nearby position was acquired by SNORA40, an snoRNA encoded by the same host gene ([fig. 3](#msz209-F3){ref-type="fig"}). Thus, we propose that the positioning of cross-talking modifications is a major force for evolutionary conservation of snoRNAs. Functionally important but independent modifications can easily switch specific antisense elements between nonhomologous modification guide RNAs. Furthermore, minimal variations in snoRNA sequence may result in rapid change of guide specificity. Such flexibility of snoRNAs provides an adaptive advantage by introducing novel posttranscriptional modifications or erasing those that became detrimental. These changes of RNA modification patterns---either adaptive or neutral---can occur in one particular taxon or even in a single species.

Closing Remarks
===============

It is commonly assumed that rRNA posttranscriptional modifications and the snoRNAs that mediate them are evolutionarily highly conserved. In fact, this is true for only a subset of modified positions and snoRNAs. The overall rate of gain and loss of function for guide RNA-mediated posttranscriptional modifications is profoundly underestimated. Although most evolutionary studies of snoRNAs focus on the comparative analysis of overall RNA sequence conservation, our data clearly demonstrate the urgent need for further studies on evolutionary conservation and variability of snoRNA guide specificities. Furthermore, experimental verification of predicted modifications and guide activities is an essential step in these studies.

Materials and Methods
=====================

RNA Preparation
---------------

RNA samples were obtained from the following species: human (HeLa cells from Yixian Zheng, Carnegie Institution; fibroblast cell line GM3814), mouse (3T3 cells from Yixian Zheng, Carnegie Institution), chicken (DF1 cells from Karen Beemon, Johns Hopkins University, and 5-day embryos from fertilized eggs purchased from Amazon), whiptail lizard *As.* *neomexicana* (total RNA and frozen embryos from Peter Baumann, Stowers Institute for Medical Research), frog *X.* *tropicalis* (liver and oocytes from females purchased from Xenopus 1), frog *X. laevis* (XTC cell line from Hélène Cousin, Boston University, liver and oocytes from females purchased from Xenopus 1), axolotl *A.* *mexicanum* (oocytes from females purchased from the Ambystoma Genetic Stock Center), newt *N.* *viridescens* (oocytes), zebrafish *D.* *rerio* (eggs, whole adult males and females of wild-type AB line from the Carnegie Institution fish facility). Trizol reagent was used to extract RNA. RNA purification was performed using the Direct-zol RNA MiniPrep kit (Zymo Research). RNA isolation from nuclei of *X. tropicalis* oocytes or GVs was described previously ([@msz209-B56]).

After ribosomal RNA depletion with the Ribozero-Gold kit (Epicenter), strand-specific libraries were generated according to the TruSeq total RNA sample preparation protocol (Illumina) using extracted human, mouse, chicken, zebrafish, and *Xenopus* RNAs. Sequencing was performed on an Illumina HiSeq 2000 sequencer as described ([@msz209-B56][@msz209-B57]). Raw RNA sequencing data were deposited at Sequence Read Archive (PRJNA302326, PRJNA479418).

Identification of snoRNA Sequences
----------------------------------

A previously generated data set of *X. tropicalis* oocyte nucleus RNA-seq (SRX4895193) was mapped with TopHat (v2.0.7) to the xenTro9 genome assembly, and intronic regions were quantified using BEDtools (v2.15.0). To detect potential snoRNA sequences, we inspected three types of intronic sequences in the Integrative Genomics Viewer (Broad Institute, v2.4.5) and looked for snoRNA motifs: 1) the top 500 most abundant introns, 2) the most abundant regions of large introns (\>1,000 bp) that were binned into 200-bp intronic fragments prior to quantification, and 3) all introns of conserved snoRNA host genes. For box C/D snoRNAs, we searched for box C (RUGAUGA) and box D (CUGA) motifs flanked by short inverted sequences. For box H/ACA snoRNAs, we screened for a "hairpin--H box (ANANNA) hinge--hairpin--ACA box tail" structure. Additionally, we performed BLAST searches for similarity with snoRNAs annotated in human and other vertebrate species.

Standard RACE-PCR (polymerase chain reaction) was used to verify 5′- and 3′-ends of newly identified *Xenopus* snoRNAs. The expression of these snoRNAs was confirmed by northern blot analysis. Total RNA was separated on 8% polyacrylamide-8M urea gels and transferred onto a nylon membrane (Zeta Probe, Bio-Rad). Hybridization and detection of digoxigenin-labeled probes were performed according to standard protocols. The presence of snoRNAs in other species was verified by examination of the recently published multispecies RNA-seq data sets (SRX4479788, SRX4479793, SRX4479799, SRX4479800, SRX4481492). The 100- or 150-bp single-end reads were mapped with TopHat (v2.0.7) to the following genomes: human (v19), mouse (v10), chicken (v5), zebrafish (v10), and *X. laevis* (v9.0). Expression of SNORA29 and SNORA100 in human and mouse was tested by northern blots.

To characterize snoRNA families, we generated cladograms based on sequence alignment using Clustal Omega with default parameters ([@msz209-B6]). We chose Clustal Omega because it is fast, efficient, suitable for this type of analysis and has been widely employed. Orthologous sequences from different taxa were selected from publicly available databases containing snoRNA annotation, such as Rfam and Ensembl. To identify unannotated orthologous snoRNAs, we used the short sequence BLAST search with query sequences corresponding to conserved antisense elements and structural motifs. Hits were screened for typical snoRNA secondary structures.

RNA Modification Analysis
-------------------------

For RNA modification mapping, we used primer extension-based methods as previously described ([@msz209-B9][@msz209-B11]). In brief, CMC treatment of test RNA was used to map pseudouridines, whereas a low concentration of dNTP in the reaction mix was used for 2′-*O*-methylation mapping. 6-FAM-labeled oligos were used for primer extension; some oligos were previously described ([@msz209-B8]; [@msz209-B10][@msz209-B13]), and the newly designed ones are depicted in [supplementary figure 4](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online. The primer extension reactions were performed using AMV (New England Biolabs) or EpiScript (Epicentre) reverse transcriptases. Single-stranded DNA fragments were precipitated, dissolved in formamide, and separated on an ABI3730xl capillary electrophoresis instrument (Applied Biosystems). The GeneScan-500 LIZ Size Standard was added to each sample. The data were analyzed using GeneMapper software (Applied Biosystems). Also, we used Oxford Nanopore technology for native RNA sequencing. Poly(A) tails were added to total RNA using poly(U) polymerase (New England Biolabs), and the Direct RNA sequencing kit (SQK-RNA001) was used to add sequencing adapters and tethers. MinKNOW software was used to run samples on MinION and to call bases. Sequences were aligned to *Xenopus* 18S, 5.8S, and 28S rRNAs and visualized using the IGV browser.

Guide RNA Activity Assays
-------------------------

We searched for potential antisense elements in all previously known and newly identified snoRNAs and screened their sequences for complementarity against U snRNAs and rRNAs. Each snoRNA in *Xenopus* and human snoRNA sets was analyzed individually. Multiple alternative configurations of each pseudouridylation pocket and alternative D/D′-box motifs with adjacent sequences were analyzed. Based on results of our previous functional tests of snoRNA modification guide activities ([@msz209-B10], [@msz209-B11], [@msz209-B12]), the minimal length of an antisense element was considered eight nucleotides for a potential pseudouridylation guide, and seven nucleotides for a 2′-*O*-methylation guide. Unpaired target uridines were placed within a pseudouridylation pocket in three conformations: U alone, UN, and UNN.

The predicted guide activities were verified using an in vivo yeast cell system. To express vertebrate snoRNAs in yeast cells, we amplified the coding sequences from genomic DNA and cloned them into YEplac181 \[LEU2 2 µ\] or YEplac195 \[URA3 2 µ\] vectors containing a GPD promoter, an RNT1 cleavage site, and an snR13 terminator ([@msz209-B19]). To express artificial substrate RNAs that contain fragments of human and *Xenopus* rRNAs or U2 snRNA, U87 scaRNA-based constructs were generated as previously described ([@msz209-B10]). The list of tested snoRNAs and their substrates is provided in [supplementary table 2](#sup1){ref-type="supplementary-material"}, [Supplementary Material](#sup1){ref-type="supplementary-material"} online. The expression constructs were introduced into yeast *S. cerevisiae* by the standard lithium acetate method. Wild type (BY4741) and several mutant strains (*pus1Δ*, *pus7Δ*, *pus4Δ*) were used. When guide RNA activity was tested on endogenous yeast RNAs, nontransformed cells served as a control. When guide RNA activity was tested on an artificial substrate RNA, yeast cells were transformed either with a substrate RNA construct alone as a control or with substrate RNA and test guide RNA constructs together. RNA was extracted from transformed and control yeast cells using a hot acid phenol method. Expression of exogenous RNAs was verified by northern blot analysis, and RNA modification assays were performed in several replicates. In addition, modification guide activities of some *Xenopus*-specific and human-specific snoRNAs were verified using vertebrate cell lines as previously described ([@msz209-B13]).

As modification mapping based on reverse transcription is only semiquantitative, we performed all reactions on control and experimental RNAs simultaneously. A modification activity was scored as positive if GeneMapper software called the peak corresponding to the predicted modification and if the peak height was at least 2- to 3-fold higher than the control base line trace (no guide RNA).

Supplementary Material
======================

###### 

Click here for additional data file.
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